Gabexate mesilate in human acute pancreatitis

Gastroenterology

Volumn 104, Issue 4, 1993, Pages 1165-1170

  Büchler, Markus ^a   Malfertheiner, Peter ^a   Uhl, Waldemar ^a   Schölmerich, Jürgen ^b   Stöckmann, Fritz ^c   Adler, Guido ^d   Gaus, Wilhelm ^a   Rolle, Klaus ^e   Beger, Hans G ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e Schwarz Pharma AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GABEXATE MESILATE; PLACEBO;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; BLEEDING; BRAIN DISEASE; DRUG EFFICACY; FEMALE; HUMAN; HYPERGLYCEMIA; HYPOCALCEMIA; ILEUS; INTRAVENOUS DRUG ADMINISTRATION; JAUNDICE; KIDNEY FAILURE; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; METABOLIC ACIDOSIS; ORAL DRUG ADMINISTRATION; PERITONITIS; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; SHOCK; SURVIVAL RATE;

ACUTE DISEASE; ADULT; AGED; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; FEMALE; GABEXATE; HUMAN; MALE; MIDDLE AGE; PANCREATITIS; PLACEBOS;

EID: 0027415147     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(93)90288-N     Document Type: Article

References (43)

1. A guide to pancreatitis
2. Acute pancreatitis: pathogenesis, outcome and treatment
3. Glucagon therapy in acute pancreatitis
4. A double blind trial of synthetic salmon calcotonin in the treatment of acute pancreatitis
5. Treatment of acute pancreatitis with somatostatin (abstr)
6. Treatment of acute pancreatitis with somatostatin (abstr)
7. Failure of glucagon in the treatment of alcoholic pancreatitis
8. A controlled trial of trasylol in the treatment of acute pancreatitis
9. Death from acute pancreatitis. M.R.C. multicentre trial of glucagon and aprotinin
10. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis
11. Acute pancreatitis: the role of lysosomes
12. Enzyme activation and liberation: intracellular/extracellular events
13. Activation of proteases in cerulein-induced pancreatitis
14. Evidence of intracellular activation of serine proteases in acute cerulein-induced pancreatitis in rats
15. Intracellular activation of digestive zymogens in rat pancreatic acini
16. Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, Clr and Cl esterase
17. Prevention of acute experimental pancreatitis in rats and dogs by intraduodenal infusion of synthetic trypsin inhibitor
18. Gabexate mesilate (Foy) protects against ceruletide-induced acute pancreatitis in the rat
19. Esterase inhibitors prevent lysosomal enzyme redistribution in two noninvasive models of experimental pancreatitis
20. Clinical experience with Foy in pancreatitis
21. Clinical use of a protease inhibitor Foy in acute pancreatitis
22. A study of Foy in the treatment of acute pancreatitis
23. Gabexat-Mesilat in der Behandlung der akuten Pankreatitis
24. Effect of synthetic protease and phospholipase A2 inhibitor gabexate mesilate (Foy) on the clinical course of patients with acute pancreatitis
25. Multicenter double-blind study of gabexate mesilate (Foy), given intravenously in low dose in acute pancreatitis (abstr)
26. 2
27. 2 activity in rabbit polymorphonuclear leukocytes
28. 2 activation by gabexate mesilate
29. 2 by gabexate esilate, camostate, and aprotinin
30. 2 in human acute pancreatitis
31. Prognostic signs and the role of operative management in acute pancreatitis
32. Controlled trial of protease inhibitor Gabexate mesilate (Foy) in the treatment of acute pancreatitis
33. Multicenter double-blind trial of gabexate mesilate (Foy) in acute pancreatitis
34. The use of ampicillin in acute pancreatitis
35. Evaluation of prophylatic antibiotics in acute pancreatitis
36. A prospective study to determine the efficacy of antibiotics in acute pancreatitis
37. Treatment of acute pancreatitis. Comparison of animal and human studies
38. Gabexat-mesilat in der Therapie der akuten Pankreatitis. Multicenterstudie zur Verträglichkeit einer hohen intravenösen Dosis (4g/Tag)
39. Localization of lysosomal and digestive enzymes in cytoplasmic vacuoles in cerulein pancreatitis
40. Apical secretion of lysosomal enzymes in rabbit pancreas occurs via a secretagogue regulated pathway and is increased after pancreatic duct obstruction
41. Effect of a specific serine protease inhibitor on the rat pancreas
42. Effect of camostat on exocrine pancreatic function in humans